Phenobarbital for Dogs: Side Effects, Dose, and Monitoring
A plain-English guide to what your dog will go through on phenobarbital. What is normal, what is not, what to track, and when to call the vet. Every fact below is sourced from the ACVIM 2015 Consensus Statement, the IVETF 2015 European Consensus, or the Merck Veterinary Manual. Your veterinarian's instructions always take priority.
The short version. Phenobarbital is still the first-line antiseizure medication for canine idiopathic epilepsy [1, 2]. Standard starting dose is 2.5 mg/kg by mouth every 12 hours, with a typical clinical range of 2 to 5 mg/kg q12h [1, 2, 3]. The target serum concentration is 15 to 35 micrograms per milliliter, with most dogs needing 25 to 30 for good seizure control [1, 2].
The common side effects (sedation, ataxia, increased drinking, eating, and urinating) are dose-related and usually settle within a few weeks [2, 3]. The serious risk is hepatotoxicity above a serum level of 35 micrograms per milliliter, which is why the level is checked at 2 weeks, 6 weeks, then every 6 months [1, 2].
Why phenobarbital is still the first choice
Despite newer drugs (levetiracetam, zonisamide, imepitoin), phenobarbital remains the first-line antiseizure medication for canine idiopathic epilepsy across three major sources. The ACVIM 2015 consensus rates it Level I, Grade A for monotherapy in dogs [1]. The IVETF describes it as a "primary treatment option" with the longest evidence record, the broadest availability, and the lowest cost [2]. The Merck Veterinary Manual professional version places it at the top of its small-animal epilepsy treatment list [3].
It is not the only first-line drug (imepitoin is approved in Europe for less severe epilepsy, and levetiracetam is sometimes used as initial monotherapy), but for a dog with frequent or severe seizures, phenobarbital is what most veterinarians reach for first.
Starting dose and titration
The published starting doses converge tightly:
- ACVIM 2015: 2.5 mg/kg orally every 12 hours [1].
- IVETF 2015: 2.5 to 3 mg/kg orally every 12 hours [2].
- Merck: 2 to 5 mg/kg orally every 12 hours, with 2 to 5 representing the broader clinical range a vet may use [3].
The dose is then titrated up based on serum levels and seizure control. Phenobarbital reaches steady state in approximately 2 to 3 weeks [3]. Adjusting the dose before steady state is reached gives a misleading reading of how the drug is actually working.
Therapeutic serum range
The target serum concentration is the same across major sources, with small wording differences:
| Source | Therapeutic range | Optimal target |
|---|---|---|
| ACVIM 2015 [1] | 15 to 35 mcg/mL | Within range, individualized |
| IVETF 2015 [2] | 15 to 40 mg/L (equivalent to mcg/mL) | 25 to 30 mg/L for most dogs |
| Merck Vet Manual [3] | 15 to 35 mcg/mL | Starting trough 20 to 25 mcg/mL |
Note: 1 mg/L of phenobarbital equals 1 microgram per milliliter (mcg/mL).
Above 35 mcg/mL, the risk of hepatotoxicity rises sharply [1, 2, 3]. That is the upper boundary every vet works against. Below 15 mcg/mL, seizure control is unlikely to be adequate.
The monitoring schedule
This is where consistent tracking from home becomes useful, because the cadence is built into the protocol.
- 2 weeks after starting: first serum phenobarbital level [1, 2].
- 6 weeks after starting: second level at steady state [1, 2].
- Baseline, 3 months, then every 6 months: CBC, biochemistry panel (including cholesterol and triglycerides), bile acid stimulation test [2].
- Every 6 to 12 months long-term: serum phenobarbital level [1, 2, 3].
- Annually if seizure-free: IVETF allows the long-term cadence to stretch to once a year in well-controlled, seizure-free dogs [2].
Note the routine difference: IVETF puts the first interim biochemistry check at 3 months; ACVIM lets that wait until 6 months [1, 2]. Your vet picks the cadence based on your dog's specific history.
Common side effects (the expected ones)
Three sources agree on the common side-effect set. They are dose-dependent and usually improve within the first 1 to 3 weeks as the dog's central nervous system adapts.
Sedation and ataxia
Your dog will likely seem drunk for the first few days. Wobbly gait, sleeping more, slow to respond. This is the most common early effect and almost always fades within 1 to 3 weeks [2, 3]. If it does not fade, the serum level may be too high.
Polydipsia and polyuria (drinking and peeing more)
Phenobarbital increases thirst and urine output. Make sure water is always available, plan for more bathroom breaks, and expect at least one nighttime trip out the door for the first few weeks [2, 3]. This often improves but does not always fully resolve.
Polyphagia (increased hunger)
Your dog will be hungrier. Without portion control, weight gain is common. Stick to the same total daily calories, divided across more meals if your dog is begging [2, 3]. Free-feeding a phenobarbital dog is a fast path to obesity.
Paradoxical hyperexcitability
A small subset of dogs show the opposite of sedation: restlessness, pacing, anxiety, or hyperactivity, especially in the first week. ACVIM specifically lists this as a documented effect [1]. If your dog seems wired rather than sleepy, call your vet.
Serious adverse effects (the rare but real ones)
Call your vet right away if you see
Yellowing of the gums or whites of the eyes (jaundice). Vomiting that does not stop, sudden refusal to eat, severe lethargy. Pale gums (possible anemia). Unexplained bleeding or bruising. Severe skin lesions or sores that do not heal. These can be signs of hepatotoxicity, blood dyscrasia, pancreatitis, or superficial necrolytic dermatitis (Sources: [1], [2], [3], [4]).
The serious effects fall into two groups:
Hepatotoxicity (the most studied)
Long-term phenobarbital at high doses can damage the liver. The cited threshold across sources is a serum level above 35 mcg/mL [1, 2, 3]. A historical case series of 18 dogs with phenobarbital-associated hepatotoxicity (Dayrell-Hart et al., JAVMA 1991) helped establish this boundary [4]. A controlled long-term study (Müller et al., JVIM 2000) showed that ALP and ALT often rise from harmless enzyme induction rather than true liver injury, but that AST, fasted bile acids, and bilirubin do reflect actual injury [5]. That is why bile acids are part of the monitoring protocol, not just routine liver enzymes.
Idiosyncratic effects (rare, less predictable)
IVETF lists the following as uncommon but documented [2]:
- Blood disorders: anemia, neutropenia, thrombocytopenia, mostly in the first 3 to 6 months [3].
- Superficial necrolytic dermatitis.
- Pancreatitis, particularly when phenobarbital is combined with potassium bromide [3].
- Movement disorders (dyskinesia).
- Anxiety changes or hypoalbuminemia.
None of these are common. They are the reasons CBC and biochemistry are checked at baseline and twice in the first year.
Drug interactions to know about
Phenobarbital is a potent inducer of liver enzymes (cytochrome P450) [2]. That has consequences for any other drug your dog takes:
- Levetiracetam (Keppra): phenobarbital significantly increases levetiracetam clearance. Dogs on both drugs usually need a higher levetiracetam dose than dogs on Keppra alone [2].
- Zonisamide and clorazepate: phenobarbital increases their clearance too [1].
- Potassium bromide (KBr): synergistic. Add-on KBr improves seizure control when phenobarbital alone is not enough [2]. Combination raises the pancreatitis risk [3].
- Diazepam (emergency rescue): dogs on chronic phenobarbital need a doubled IV or rectal diazepam dose for status epilepticus [2].
- Corticosteroids (prednisone): enzyme induction can reduce corticosteroid effect [2].
Always tell every vet (including specialists, ER vets, and groomers if they ask about meds) that your dog is on phenobarbital.
Missed dose: what the guidelines actually say
An honest answer: ACVIM, IVETF, and the Merck Veterinary Manual do not publish explicit missed-dose rules for canine phenobarbital. The standard pharmacy convention applies. If you remember within a couple of hours of the missed dose, give it. If it is closer to the next dose, skip and continue. Never double a dose to make up.
What is published, and important: phenobarbital must never be stopped abruptly. Withdrawal can trigger seizures or status epilepticus [2]. If you have run out, get a refill immediately, and call your vet if there is going to be a gap of more than one dose.
Stopping phenobarbital: only with a slow taper
If your dog has been seizure-free for an extended period, your vet may discuss tapering off. The rules:
- Minimum seizure-free interval before tapering: 1 to 2 years [2].
- Taper rate: reduce the dose by 20 percent or less per month [2].
- Merck's broader language: "taper gradually over a few weeks" [3]. IVETF's monthly 20 percent rule is more conservative and specifically aimed at canine idiopathic epilepsy.
Going faster than this risks rebound seizures, which can be more severe than the original ones.
When to escalate to a second drug
No major guideline gives a specific seizure-frequency threshold (like "more than 1 seizure per month") for adding a second antiseizure medication. The decision is qualitative [1, 2]. The general criteria across ACVIM, IVETF, and Merck:
- Phenobarbital serum level is in the upper therapeutic range (close to 35 mcg/mL) without adequate seizure control.
- Cluster seizures or status epilepticus are still occurring.
- Side effects at the dose required are unacceptable.
At that point, the usual add-on choices are potassium bromide or levetiracetam (with levetiracetam dose adjusted upward to account for phenobarbital's enzyme induction) [1, 2]. Some dogs end up on phenobarbital plus KBr plus levetiracetam. That decision is your veterinarian's.
Tracking phenobarbital at home so you can hand the log to your vet
Phenobarbital therapy is built around precise timing (twice a day at the same hours, every day) and observed adherence. The recheck conversation always starts with the same questions: how many doses were missed, were there any seizures, what side effects did you notice, when was the last serum level. A reliable home log makes those answers honest.
Remewdy is a free iPhone app that logs each dose in one tap, sends reminders at the times you set, and records seizure events with type, duration, and post-seizure notes. The compliance heat map shows the last 4 to 12 weeks of dosing at a glance. Premium users print a PDF summary for the vet that combines dose history, seizure events, weight, and notes.
The app does not prescribe, change doses, or interpret bloodwork. It does the boring part: keeping the record straight so your vet can do the medical part well.
Track every dose, every seizure, free
Free for 1 dog, full feature set. No account. No cloud. Records live on your iPhone. Works offline. Export to CSV any time.
Download Remewdy FreeFrequently Asked Questions
ACVIM and IVETF both recommend a starting dose of 2.5 mg/kg orally every 12 hours, with Merck citing a 2 to 5 mg/kg clinical range every 12 hours [1, 2, 3]. The dose is titrated to a therapeutic serum concentration of 15 to 35 micrograms per milliliter. Always follow your veterinarian's prescription.
Sedation, ataxia (wobbly walking), polyuria and polydipsia (more drinking and urinating), and polyphagia (more eating). Dose-dependent and most often improve within 1 to 3 weeks [2, 3]. Some dogs show paradoxical hyperexcitability rather than sedation [1].
Above 35 micrograms per milliliter, the risk of hepatotoxicity rises sharply and that level should be avoided [1, 2, 3]. The therapeutic target is 15 to 35 mcg/mL, with most dogs in the 25 to 30 range for good seizure control.
First level at 2 weeks after starting, second at 6 weeks (steady state), then every 6 months long-term, or annually if seizure-free [1, 2]. CBC, biochemistry, and bile acid stimulation test at baseline, at 3 months, then every 6 months [2].
Long-term phenobarbital at serum levels above 35 mcg/mL is associated with hepatotoxicity [1, 2, 4]. Routine ALP and ALT elevations on phenobarbital often reflect harmless enzyme induction; bile acids and AST are more reliable injury markers (Müller et al., JVIM 2000) [5]. That is why bile acids are part of the monitoring protocol.
ACVIM, IVETF, and Merck do not publish explicit missed-dose rules. Standard pharmacy convention applies: give the missed dose if you remember within a couple of hours; otherwise skip it and continue. Never double up. Always follow your vet's instructions. Phenobarbital should never be stopped abruptly because withdrawal can trigger seizures or status epilepticus [2].
Only with a slow taper, never abruptly. IVETF recommends reducing the dose by 20 percent or less per month, and only after a seizure-free interval of 1 to 2 years [2]. The decision is your veterinarian's.
Yes. Phenobarbital induces liver enzymes and increases the clearance of levetiracetam, zonisamide, clorazepate, and corticosteroids [1, 2]. The diazepam emergency rescue dose for status epilepticus must be doubled in dogs on chronic phenobarbital [2]. The combination of phenobarbital and potassium bromide raises pancreatitis risk [3]. Always inform every vet about every drug your dog is on.
Sources
- [1] Podell M, Volk HA, Berendt M, Loscher W, Munana K, Patterson EE, Platt SR. 2015 ACVIM Small Animal Consensus Statement on Seizure Management in Dogs. Journal of Veterinary Internal Medicine, 2016;30(2):477 to 490. https://pmc.ncbi.nlm.nih.gov/articles/PMC4913615/
- [2] Bhatti SFM, De Risio L, Munana K, Penderis J, Stein VM, Tipold A, Berendt M, Farquhar RG, Fischer A, Long S, Loscher W, Mandigers PJJ, Matiasek K, Pakozdy A, Patterson EE, Platt S, Podell M, Potschka H, Rusbridge C, Volk HA. International Veterinary Epilepsy Task Force Consensus Proposal: Medical Treatment of Canine Epilepsy in Europe. BMC Veterinary Research, 2015;11:176. https://pmc.ncbi.nlm.nih.gov/articles/PMC4552371/
- [3] Merck Veterinary Manual, professional version. Anticonvulsants for Treatment of Animals; Epilepsy in Small Animals. Anticonvulsants entry. Epilepsy entry.
- [4] Dayrell-Hart B, Steinberg SA, VanWinkle TJ, Farnbach GC. Hepatotoxicity of Phenobarbital in Dogs: 18 cases (1985 to 1989). Journal of the American Veterinary Medical Association, 1991;199(8):1060 to 1066. https://pubmed.ncbi.nlm.nih.gov/1748613/
- [5] Muller PB, Taboada J, Hosgood G, Partington BP, VanSteenhouse JL, Taylor HW, Wolfsheimer KJ. Effects of Long-Term Phenobarbital Treatment on the Liver in Dogs. Journal of Veterinary Internal Medicine, 2000;14(2):165 to 171. https://pmc.ncbi.nlm.nih.gov/articles/PMC7197517/